The Antinociceptive Effect of a Benzopyran (HP1) Isolated from Hypericum polyanthemum in Mice Hot-Plate Test is Blocked by Naloxone

Abstract

Several species of the genus Hypericum (Guttiferae) have been used for analgesic purposes all over the world and some of them have demonstrated to possess this effect in rodents. This study describes the antinociceptive effect of the cyclohexane extract from aerial parts of H. polyanthemum (POL) as well as of benzopyrans, 6-isobutyryl-5,7-dimethoxy-2,2-dimethyl-benzopyran (HP1), 7-hydroxy-6-isobutyryl-5-methoxy-2,2-dimethyl-benzopyran (HP2), and 5-hydroxy-6-isobutyryl-7-methoxy-2,2-dimethyl-benzopyran (HP3), which are the main components of POL. The antinociceptive effect was evaluated through hot-plate and writhing tests in mice, and the opioid system involvement was assessed by using naloxone (2.5 mg/kg, s. c.) antagonism. In the hot-plate test, POL (45, 90, 180 mg/kg, p.o) showed a dose-dependent effect, and out of the benzopyrans only HP1 (30, 60, 90 mg/kg, i. p.) was active. Its effect was also dose-dependent, with the maximum reached at 60 mg/kg. HP1 60 mg/kg (p. o.) also inhibited acetic acid-induced writhing in 58 %. The pretreatment with naloxone abolished the antinociceptive effect of HP1 60 mg/kg (i.p) in the hot plate. Furthermore, the H. polyanthemum cyclohexane extract and HP1 did not affect the mice performance in the rota-rod apparatus suggesting that at antinociceptive doses they do not present gross neurotoxicity nor induce motor impairment. From these data it is reasonable to assume that the benzopyran HP1 accounts for the H. polyanthemum cyclohexane extract antinociceptive effect, and this effect is, at least in part, mediated by an opioid-like mechanism.

Key words

Hypericum polyanthemum - Guttiferae - benzopyrans - antinociceptive effect

References

• 1 Mendes F R, Mattei R, Carlini E L A. Activity of Hypericum brasiliense and Hypericum cordatum on the central nervous system in rodents.  Fitoterapia. 2002;  73 462-471
• 2 Rabanal R M, Bonkanka C X, Hernández-Pérez M, Sánchez-Mateo C C. Analgesic and topical anti-inflammatory activity of Hypericum canariense L. and Hypericum glandulosum Ait.  J Ethnopharmacol. 2005;  96 591-596
• 3 Sánchez-Mateo C C, Bonkanka C X, Hernández-Pérez M, Rabanal R M. Evaluation of the analgesic and topical anti-inflammatory effects of Hypericum reflexum L. fil.  J Ethnopharmacol. 2006;  107 1-6
• 4 Mentz L A, Lutzemberger L C, Schenkel E P. Da flora medicinal do Rio Grande do Sul: notas sobre a obra de D'Avila (1910).  Caderno de Farmácia. 1997;  15 25-47
• 5 Viana A F, Heckler A P, Fenner R, Rates S M K. Antinociceptive activity of Hypericum caprifoliatum and Hypericum polyanthemum (Guttiferae).  Braz J Med Biol Res. 2003;  36 631-634
• 6 Ferraz A B F, Bordignon S A L, Staats C, Schripsema J, von Poser G L. Benzopyrans from Hypericum polyanthemum.  Phytochemistry. 2001;  57 1227-1230
• 7 Gnerre C, von Poser G L, Ferraz A, Viana A, Testa B, Rates S M K. Monoamine oxidase inhibitory activity of some Hypericum species native to South Brazil.  J Pharm Pharmacol. 2001;  53 1273-1279
• 8 Dall'Agnol R, Ferraz A, Bernardi A P, Albring D, Nör C, Schapoval E E S, von Poser G L. Bioassay-guided isolation of antimicrobial benzopyrans and phloroglucinol derivatives from Hypericum species.  Phytother Res. 2005;  19 291-293
• 9 Ferraz A B F, Grivicich I, von Poser G L, Faria D H, Kayser G B, Schwartsmann G, Henriques A T, da Rocha A B. Antitumor activity of three benzopyrans isolated from Hypericum polyanthemum.  Fitoterapia. 2005;  76 210-215
• 10 Grivicich I, Ferraz A, Faria D H, Regner A, Schwartsmann G, Henriques A T, von Poser G L, da Rocha A B. Synergistic effect of three benzopyrans isolated from Hypericum polyanthemum in U-373 MG glioblastoma cell line.  Phytother Res. 2008;  22 1577-1580
• 11 Ferraz A B F, da Silva J, Deimlimg L I, Santos-Mello R, Sharlau A, von Poser G L, Picada J N. Genotoxicity evaluation of three benzopyrans from Hypericum polyanthemum.  Planta Med. 2009;  75 37-40
• 12 Cargnin S T, de Matos Nunes J, Haas J S, Baladão L F, Cassel E, Vargas R F, Rech S B, von Poser G L. Supercritical fluid extraction and high performance liquid chromatographic determination of benzopyrans and phloroglucinol derivative in Hypericum polyanthemum.  J Chromatogr B Anal Technol Biomed Life Sci. 2010;  878 83-87
• 13 Brasil Congresso Nacional .Lei n. 11794. Regulamenta o inciso VII do § 1° do artigo 225 da Constituição Federal, estabelecendo procedimentos para o uso científico de animais. Revoga a lei nº 6638, de 8 de maio de 1979 e dá outras providências. D.O.U., Brasília, 8 de outubro de 2008. 
• 14 Bankowski Z. CIOMS. Council for International Organization of Medical Sciences International guiding principles for biomedical research involving animals. 1985 http://www.cioms.ch/frame_1985_texts_of_guidelines.htm Accessed September 30, 2009
• 15 Dunham N W, Miya T S. A note on a simple apparatus for detecting neurological deficit in rats and mice.  J Am Pharm Assoc Am Pharm Assoc (Baltim). 1957;  46 208-209
• 16 Le Bars D, Gozariu M, Cadden S W. Animal models of nociception.  Pharmacol Rev. 2001;  53 597-652
• 17 Pearl J, Stander H, McKean D B. Effects of analgesics and other drugs on mice in phenylquinone and rotorod tests.  J Pharmacol Exp Ther. 1969;  167 9-13
• 18 Heckler A P M, Viana A F, Fenner R, Nor C, Kliemann M, do Rego J C, Costentin J, von Poser G L, Rates S M K. Atividade antinociceptiva de uliginosina isolada de Hypericum polyanthemum (Guttiferae). Águas de Lindóia; 20ª Reunião da Federação de Sociedades de Biologia Experimental 2005
• 19 Parsons A A, Bingham S, Raval P, Read S, Thompson M, Upton N. Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes.  Br J Pharmacol. 2001;  132 1549-1557
• 20 Prasanna S, Manivannan E, Chaturvedi S C. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.  Bioorg Med Chem Lett. 2004;  14 4005-4011
• 21 Gierse J, Nickols M, Leahy K, Warner J, Zhang Y, Cortes-Burgos L, Carter J, Seibert K, Masferrer J. Evalaution of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.  Eur J Pharmacol. 2008;  588 93-98
• 22 Eissa A A M, Farag N A H, Soliman G A H. Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.  Bioorg Med Chem. 2009;  17 5059-5070
• 23 Cichewicz D L. Synergistic interactions between cannabinoid and opioid analgesics.  Life Sci. 2004;  74 1317-1324
• 24 Welch S P. Interaction of the cannabinoid and opioid systems in the modulation of nociception.  Int Rev Psychiatry. 2009;  21 143-151
• 25 Mennini T, Gobbi M. The antidepressant mechanism of Hypericum perforatum.  Life Sci. 2004;  75 1021-1027
• 26 Chen F, Rezvani A H, Lawrence A J. Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St. John's wort treatment.  Naunyn Schmiedebergs Arch Pharmacol. 2003;  367 126-133
• 27 Perfumi M, Mattioli L, Cucculelli M, Massi M. Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats.  J Psychopharmacol. 2005;  19 448-454

1 These authors have contributed equally to the studies presented in this manuscript.